Inici › Càncer de mama › Texas › Austin
Assaigs clínics de Càncer de mama a Austin, TX
18 estudis de Càncer de mama busquen participants en centres de Austin i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
ReclutantFase 1/2
- New Experimental Therapeutics - NEXT Oncology, Austin
An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
ReclutantFase 1
- Next Oncology Austin, Austin
A Phase 1/1b Study of IAM1363 in HER2 Cancers
ReclutantFase 1
- NEXT Oncology - Austin, Austin
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
ReclutantFase 1/2
- Texas Oncology, Austin
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
ReclutantFase 3
- Texas Oncology Central/South, Austin
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
ReclutantFase 1
- NEXT Austin, Austin
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
ReclutantFase 2/3
- Texas Oncology - Central/South Texas, Austin
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
ReclutantFase 3
- Texas Oncology - Austin, Austin
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
ReclutantFase 1/2
- Texas Oncology - Central / South Texas, Austin
Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer
ReclutantFase 1/2
- Texas Oncology - Central/South, Austin
Cancer Pain Management Using a Web-based Intervention
Reclutant
- The University of Texas at Austin, Austin
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
ReclutantFase 3
- Texas Oncology - Central South (Balcones Dr), Austin
- Texas Oncology - Central South (James Casey), Austin
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
ReclutantFase 1
- NEXT Oncology Austin, Austin
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
ReclutantEstudi observacionalVoluntaris sans benvinguts
- Elligo Health Research, Inc., Austin
Sample Collection for Ongoing Research and Product Evaluation Study
ReclutantEstudi observacional
- Natera, Inc., Austin
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
ReclutantFase 1
- Exelixis Clinical Site #4, Austin
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
ReclutantEstudi observacional
- Texas Oncology - Austin, Austin
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
ReclutantFase 2
- Texas Oncology PA (Austin), Austin
Assaigs de Càncer de mama en altres ciutats
- New York City, NY134 estudis
- Houston, TX126 estudis
- Boston, MA111 estudis
- Nashville, TN80 estudis
- Los Angeles, CA72 estudis
- Edison, NJ68 estudis
- St. Louis, MO64 estudis
- Durham, NC63 estudis
- Queens, NY63 estudis
- Chicago, IL58 estudis
- Philadelphia, PA56 estudis
- Dallas, TX55 estudis
Altres estudis a Austin
- Càncer de pulmó de cèl·lules no petites30 estudis
- Càncer (tots els tipus)20 estudis
- Obesitat20 estudis
- Càncer metastàtic19 estudis
- Càncer colorrectal19 estudis
- Insuficiència cardíaca18 estudis
- Sobrepès18 estudis
- Càncer d'ovari17 estudis
- Càncer d'endometri15 estudis
- Càncer de pròstata15 estudis
- Depressió14 estudis
- Càncer de mama triple negatiu13 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.